Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Galantamine is a well-studied compound primarily used in the management of Alzheimer's disease. Its main mechanism of action is as a reversible, competitive inhibitor of acetylcholinesterase, the enzyme responsible for breaking down the neurotransmitter acetylcholine in the brain. By inhibiting this enzyme, galantamine increases the concentration and duration of action of acetylcholine at synaptic junctions, thereby supporting cholinergic neurotransmission. Additionally, galantamine acts as an allosteric modulator at nicotinic acetylcholine receptors, further enhancing cholinergic signaling.

The use of galantamine for cognitive support is supported by numerous randomized controlled trials and meta-analyses. Clinical studies have demonstrated that galantamine can result in modest improvements in cognitive function, activities of daily living, and global clinical status in patients with mild to moderate Alzheimer's disease. These findings have led to its approval by regulatory agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of Alzheimer's disease.

While its use is primarily restricted to pathological conditions involving cholinergic deficits, such as Alzheimer's, galantamine’s ability to enhance acetylcholine activity is a clear example of supporting the "Specific Neurotransmitters" body system—specifically, the cholinergic system. However, there is little evidence supporting its use in healthy individuals for cognitive enhancement, and its use outside of approved indications is not well substantiated by research.

More about Galantamine
More about Specific Neurotransmitters

Other ingredients that support Specific Neurotransmitters

Other body systems supported by Galantamine

Products containing Galantamine